Annals of Pediatric Cardiology
About us | Current Issue | Archives | Ahead of Print | Instructions | Submission | Subscribe | Advertise | Contact | Login 


    Advanced search

    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  

   Case Report
    Article Figures

 Article Access Statistics
    PDF Downloaded188    
    Comments [Add]    
    Cited by others 14    

Recommend this journal


Table of Contents   
Year : 2011  |  Volume : 4  |  Issue : 2  |  Page : 204-206
Hutchinson-Gilford progeria syndrome with severe calcific aortic valve stenosis

Department of Pediatric Cardiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bangalore, India

Click here for correspondence address and email

Date of Web Publication8-Sep-2011


Hutchinson-Gilford progeria syndrome (HGPS) is a rare premature aging syndrome that results from mutation in the Laminin A gene. This case report of a 12-year-old girl with HGPS is presented for the rarity of the syndrome and the classical clinical features that were observed in the patient. All patients with this condition should undergo early and periodic evaluation for cardiovascular diseases. However, the prognosis is poor and management is mainly conservative. There is no proven therapy available. Mortality in this uniformly fatal condition is primarily due to myocardial infarction, strokes or congestive cardiac failure between ages 7 and 21 years due to the rapidly progressive arteriosclerosis involving the large vessels.

Keywords: Aortic valve stenosis, laminin A, premature ageing, progeria syndrome

How to cite this article:
Hanumanthappa NB, Madhusudan G, Mahimarangaiah J, Manjunath CN. Hutchinson-Gilford progeria syndrome with severe calcific aortic valve stenosis. Ann Pediatr Card 2011;4:204-6

How to cite this URL:
Hanumanthappa NB, Madhusudan G, Mahimarangaiah J, Manjunath CN. Hutchinson-Gilford progeria syndrome with severe calcific aortic valve stenosis. Ann Pediatr Card [serial online] 2011 [cited 2022 Jul 4];4:204-6. Available from:

   Introduction Top

 Hutchinson-Gilford progeria More Details syndrome (HGPS) is a rare premature ageing syndrome that is uniformly fatal and affects a variety of organ systems. Death in HGPS is caused primarily by myocardial infarction usually between ages 7 and 21 years as a result of rapidly progressive arteriosclerosis. [1] Death is often preceded by hypertension, transient ischemic attacks and strokes. This case report of a child with HGPS is presented because of the rarity of this syndrome and the classical clinical findings that were observed.

   Case Report Top

A 12-year-old girl, the youngest of three siblings, born of a nonconsanguineous marriage, and who had a normal perinatal history, was referred for evaluation of an incidentally detected cardiac murmur. There was failure to thrive but otherwise the patient was asymptomatic. There was no history of chest pain, syncope or palpitations. There was no family history of cardiac disease or genetic syndromes. The child had normal motor and mental development with normal intelligence. She had not attained menarche and her physical examination revealed short stature, craniofacial disproportion, shrunken facies, alopecia, prominent scalp veins, prominent eyes, micrognathia, a "beaked" nose, prominent and stiff joints, dystrophic nails, thin wrinkled skin and absent secondary sexual characteristics suggestive of a premature ageing syndrome [Figure 1] and [Figure 2]. The above-mentioned abnormal features were noted to appear after infancy.
Figure 1: Side Photograph of the child showing the typical phenotypic features of the Hutchinson-Gilford progeria syndrome

Click here to view
Figure 2: Front Photograph of the child showing the typical phenotypic features of the Hutchinson-Gilford progeria syndrome

Click here to view

The blood pressure was 128/92 mmHg, and all pulses were palpable, but feeble. There was bilateral carotid shudder. There was no brachiofemoral delay and clinical findings suggestive of severe aortic stenosis were present. Electrocardiography revealed left ventricular hypertrophy with a strain pattern. Echocardiography showed calcified aortic cusps with severe aortic stenosis (peak systolic gradient of 72 mmHg, mean gradient of 52 mmHg), mild aortic regurgitation and moderate mitral regurgitation [Figure 3]. There was concentric left ventricular hypertrophy with normal function (ejection fraction 57%). The aortic valve area was estimated to be 0.7 cm 2 . The patient's lipid profile revealed hypercholesterolemia with elevated low-density lipoprotein cholesterol and normal high-density lipoprotein cholesterol. It was decided to manage the patient conservatively as the outcome of aortic valve balloon dilatation/surgical replacement in this condition is not well documented and also because of the extremely fragile general condition of the patient.
Figure 3: Echocardiographic image in an apical five-chamber view showing severe aortic stenosis with turbulence across the valve on color Doppler echocardiography

Click here to view

   Discussion Top

HGPS has long been a source of fascination and curiosity. Since its first description, about 100 cases have been documented worldwide. HGPS is characterized by features reminiscent of normal ageing such as alopecia, skin wrinkling and osteoporosis. The most devastating aspect of this disease, however, is accelerated, premature cardiovascular disease that leads to fatal myocardial infarction or stroke by an average age of 13 years. [2] It is caused by a single base mutation in the LMNA gene, a laminopathy, which results in the production of a mutant lamin A protein product, progerin. [1],[2],[3] Laminin A is an essential scaffolding component of the nuclear envelope, which is the membrane that surrounds the nucleus. The altered protein in HGPS makes the nuclear envelope unstable and progressively damages the nucleus, making cells more likely to die prematurely.

The diagnosis of HGPS is essentially clinical, [4] as in the present patient, although other diseases may phenotypically mimic HGPS early in life (i.e.,  Wiedemann-Rautenstrauch syndrome More Details and restrictive dermopathy). [5] The characteristic features are usually recognized during the second year of life. [4] Most of the signs and symptoms, as well as the cause of death, result from the complications of sclerosis.

Cardiac involvement manifests as coronary artery disease, valvar stenosis and hypertension. [6],[7] In a review of 32 cases of progeria, Makous et al. [7] observed cardiovascular system involvement in 31 patients who were aged from 2 to 26 years. A highly accelerated calcific deposition was seen to occur in the coronary, aortic, cerebral, subclavian and axillary arteries, mitral annulus and aortic valve cusps. [4] The calcific aortic valve sclerosis represents a degenerative change that is an exaggeration of normal ageing and involves principally the anterior mitral valve cusp and the proximal aortic valve cusps. [6],[8] Death usually occurs within 4 years after the onset of angina pectoris as a result of acute coronary insufficiency with or without myocardial infarction. Heart failure may precede death. [5] Systemic hypertension is common and may appear before the patient reaches the age of 5 years. The condition carries a poor prognosis and no effective therapy is currently approved. However, some experimental drugs are undergoing trials. [8] One of them is Lonafarnib, a farnesyltransferase inhibitor that blocks the posttranslational farnesylation of prelamin A. Farnesylation is essential for the function of both mutant and nonmutant lamin A proteins, including progerin ( number, NCT000425607). Another treatment attempted is the combination of two molecules - zoledronic acid and pravastatin ( number, NCT00731016). Presently, the average life expectancy in progeria is 13 years (range: 7-27 years), [9] with death resulting from cardiovascular abnormalities, usually myocardial infarction, stroke or congestive cardiac failure, in 75% of the cases. [2]

In conclusion Hutchinson-Gilford progeria is a rare disease characterized by accelerated signs of ageing.that result from mutation in lMNA gene. Cardiovascular involvement is the commonest cause of death and prognosis remains poor.

   References Top

1.Hennekam RC. Hutchinson-Gilford progeria syndrome: Review of the phenotype. Am J Med Genet A 2006;140:2603-24.  Back to cited text no. 1
2.DeBusk FL. The Hutchinson-Gilford progeria syndrome: Report of 4 cases and review of the literature. J Pediatr 1972;80:697-724.  Back to cited text no. 2
3.De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, et al. Lamin A truncation in Hutchinson-Gilford progeria. Science 2003;300:2055.  Back to cited text no. 3
4.Badame AJ. Progeria. Arch Dermatol 1989;125:540-4.  Back to cited text no. 4
5.Csoka AB, Cao H, Sammak PJ, Constantinescu D, Schatten GP, Hegele RA. Novel lamin A/C gene (LMNA) mutations in atypical progeroid syndromes. J Med Genet 2004;41:304-8.  Back to cited text no. 5
6.Nair K, Ramachandran P, Krishnamoorthy KM, Dora S, Achuthan TJ. Hutchinson-Gilford progeria syndrome with severe calcific aortic valve stenosis and calcific mitral valve. J Heart Valve Dis 2004;13:866-9.  Back to cited text no. 6
7.Makous N, Friedman S, Yakovac W, Maris EP. Cardiovascular manifestations in progeria. Report of clinical and pathologic findings in a patient with severe arteriosclerotic heart disease and aortic stenosis. Am Heart J 1962;64:334-46.  Back to cited text no. 7
8.Merideth MA, Gordon LB, Clauss S, Sachdev V, Smith AC, Perry MB, et al. Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med 2008;358:592-604.  Back to cited text no. 8
9.Ishili T. Progeria: Autopsy report of one case, with a review of pathologic findings reported in the literature. J Am Geriatr Soc 1976;24:193-202.  Back to cited text no. 9

Correspondence Address:
Ganigara Madhusudan
Department of Pediatric Cardiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Jayanagar 9th Block, Bannerghatta Road, Bangalore 560 069, Karnataka
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0974-2069.84670

Rights and Permissions


  [Figure 1], [Figure 2], [Figure 3]

This article has been cited by
1 Dermatologic manifestations of pediatric cardiovascular diseases: Skin as a reflection of the heart
Virginia A. Jones, Payal M. Patel, Tom Valikodath, Kurt A. Ashack
Pediatric Dermatology. 2021;
[Pubmed] | [DOI]
2 Mitochondrial Dysfunction: Cause or Consequence of Vascular Calcification?
Kanchan Phadwal, Christina Vrahnas, Ian G. Ganley, Vicky E. MacRae
Frontiers in Cell and Developmental Biology. 2021; 9
[Pubmed] | [DOI]
3 Identification of common cardiometabolic alterations and deregulated pathways in mouse and pig models of aging
Víctor Fanjul, Inmaculada Jorge, Emilio Camafeita, Álvaro Macías, Cristina González-Gómez, Ana Barettino, Beatriz Dorado, María Jesús Andrés-Manzano, José Rivera-Torres, Jesús Vázquez, Carlos López-Otín, Vicente Andrés
Aging Cell. 2020; 19(9)
[Pubmed] | [DOI]
4 Dietary magnesium supplementation improves lifespan in a mouse model of progeria
Ricardo Villa-Bellosta
EMBO Molecular Medicine. 2020; 12(10)
[Pubmed] | [DOI]
5 Hutchinson-Gilford Progeria Syndrome and Severe Aortic Stenosis: A New Hope for Treatment
Francesco Musumeci, Antonio Giovanni Cammardella, Antonio Lio, Carmine Musto, Vincenzo Polizzi, Vitaliano Buffa, Andrea Montalto, Marina Comisso, Federico Ranocchi, Mauro Cassese
The Annals of Thoracic Surgery. 2020; 110(5): e365
[Pubmed] | [DOI]
6 ATP-based therapy prevents vascular calcification and extends longevity in a mouse model of Hutchinson–Gilford progeria syndrome
Ricardo Villa-Bellosta
Proceedings of the National Academy of Sciences. 2019; 116(47): 23698
[Pubmed] | [DOI]
7 Aging in the Cardiovascular System: Lessons from Hutchinson-Gilford Progeria Syndrome
Magda R. Hamczyk, Lara del Campo, Vicente Andrés
Annual Review of Physiology. 2018; 80(1): 27
[Pubmed] | [DOI]
8 Heart rate reduction and longevity in mice
Sabine Gent,Petra Kleinbongard,Philip Dammann,Markus Neuhäuser,Gerd Heusch
Basic Research in Cardiology. 2015; 110(2)
[Pubmed] | [DOI]
9 LMNA-associated cardiocutaneous progeria: An inherited autosomal dominant premature aging syndrome with late onset
Megan S. Kane,Mark E. Lindsay,Daniel P. Judge,Jemima Barrowman,Colette Ap Rhys,Lisa Simonson,Harry C. Dietz,Susan Michaelis
American Journal of Medical Genetics Part A. 2013; 161(7): 1599
[Pubmed] | [DOI]
10 LMNA-associated cardiocutaneous progeria: An inherited autosomal dominant premature aging syndrome with late onset
Kane, M.S. and Lindsay, M.E. and Judge, D.P. and Barrowman, J. and Ap Rhys, C. and Simonson, L. and Dietz, H.C. and Michaelis, S.
American Journal of Medical Genetics, Part A. 2013; 161(7): 1599-1611
11 Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment
Villa-Bellosta, R. and Rivera-Torres, J. and Osorio, F.G. and Acín-Pérez, R. and Enriquez, J.A. and López-Otín, C. and Andrés, V.
Circulation. 2013; 127(24): 2442-2451
12 Defective Extracellular Pyrophosphate Metabolism Promotes Vascular Calcification in a Mouse Model of Hutchinson-Gilford Progeria Syndrome That Is Ameliorated on Pyrophosphate Treatment
Ricardo Villa-Bellosta, José Rivera-Torres, Fernando G. Osorio, Rebeca Acín-Pérez, José A. Enriquez, Carlos López-Otín, Vicente Andrés
Circulation. 2013; 127(24): 2442
[Pubmed] | [DOI]
13 Wiedemann-Rautenstrauch syndrome: Report of a variant case
Kiraz, A., Ozen, S., Tubas, F., Usta, Y., Aldemir, O., Alanay, Y.
American Journal of Medical Genetics, Part A. 2012; 158A(6): 1434-1436
14 Wiedemann-Rautenstrauch syndrome: Report of a variant case
Aslihan Kiraz,Samim Ozen,Filiz Tubas,Yusuf Usta,Ozgur Aldemir,Yasemin Alanay
American Journal of Medical Genetics Part A. 2012; 158A(6): 1434
[Pubmed] | [DOI]